nach oben

Breast Cancer

Erschienen in:

01.09.2014 | Review Article

Functional significance of long non-coding RNAs in breast cancer

verfasst von: Rajeev Vikram, Rahul Ramachandran, Khaja Shameem Mohammed Abdul

Erschienen in: Breast Cancer | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Most of the genome is transcribed to transcripts of no protein-coding potential. However, these transcripts do not represent transcriptional ‘noise’, rather they play an important role in cellular metabolism and development. Non-coding transcripts of 200 bases to 100 kb length are termed as long non-coding RNAs, majority of which are yet to be characterised thoroughly. Long non-coding RNAs (lncRNAs) play a significant role in cellular process ranging from transcriptional to post-transcriptional regulation. In this review, we highlight the recent efforts to characterise the major functions of lncRNAs in breast cancer. lncRNA expression is altered in several cancer types. Further, the aberrant regulation of lncRNAs promotes tumour development as they are involved in several cancer-associated pathways.

Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, et al. The transcriptional landscape of the mammalian genome. Science. 2005;309:1559–63.PubMedCrossRef

Kapranov P. Studying chromosome-wide transcriptional networks: new insights into disease? Genome Med. 2009;1:50.PubMedCentralPubMedCrossRef

Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–9.PubMedCrossRef

Van Bakel H, Hughes TR. Establishing legitimacy and function in the new transcriptome. Brief Funct Genomic Proteomic. 2009;8:424–36.PubMedCrossRef

Wang J, Zhang J, Zheng H, Li J, Liu D, Li H, et al. Mouse transcriptome: neutral evolution of “non-coding” complementary DNAs. Nature. 2004;431:1.PubMed

Struhl K. Transcriptional noise and the fidelity of initiation by RNA polymerase II. Nat Struct Mol Biol. 2007;14:103–5.PubMedCrossRef

Van Bakel H, Nislow C, Blencowe BJ, Hughes TR. Most “dark matter” transcripts are associated with known genes. PLoS Biol. 2010;8:e1000371.PubMedCentralPubMedCrossRef

Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009;23:1494–504.PubMedCentralPubMedCrossRef

Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:629–41.PubMedCrossRef

10.

Mitra S, Mitra AP, Triche TJ. A central role for long non-coding RNA in cancer. Front Genet. 2012;3:17.PubMedCentralPubMed

11.

Hung T, Chang HY. Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol. 2010;7:582–5.PubMedCentralPubMedCrossRef

12.

Moazed D. Small RNAs in transcriptional gene silencing and genome defence. Nature. 2009;457:413–20.PubMedCentralPubMedCrossRef

13.

Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136:642–55.PubMedCentralPubMedCrossRef

14.

Siomi H, Siomi MC. On the road to reading the RNA-interference code. Nature. 2009;457:396–404.PubMedCrossRef

15.

Brennecke J, Aravin AA, Stark A, Dus M, Kellis M, Sachidanandam R, et al. Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila. Cell. 2007;128:1089–103.PubMedCrossRef

16.

Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904–14.PubMedCentralPubMedCrossRef

17.

Nagano T, Fraser P. No-nonsense functions for long noncoding RNAs. Cell. 2011;145:178–81.PubMedCrossRef

18.

Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 2007;316:1484–8.PubMedCrossRef

19.

Wu JM, Fackler MJ, Halushka MK, Molavi DW, Taylor ME, Teo WW, et al. Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res. 2008;14:1938–46.PubMedCentralPubMedCrossRef

20.

Khalil AM, Rinn JL. RNA–protein interactions in human health and disease. Semin Cell Dev Biol. 2011;22:359–65.PubMedCentralPubMedCrossRef

21.

Wang X, Song X, Glass CK, Rosenfeld MG. The long arm of long noncoding RNAs: roles as sensors regulating gene transcriptional programs. Cold Spring Harb Perspect Biol. 2011;3:a003756.PubMedCentralPubMedCrossRef

22.

Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21:354–61.PubMedCrossRef

23.

Kosir M, Jia H, Ju D, Lipovich L. Challenging paradigms: long non-coding RNAs in breast ductal carcinoma in situ (DCIS). Front Genet. 2013;4:50.PubMedCentralPubMed

24.

Sun M, Kraus WL. Minireview: long noncoding RNAs: new “links” between gene expression and cellular outcomes in endocrinology. Mol Endocrinol. 2013;27:1390–402.PubMedCrossRef

25.

Nagano K. Search for breast cancer-related biomarker proteins for drug discovery (in Japanese with English abstract). Yakugaku Zassh. 2010;130:1701–6.CrossRef

26.

Negrini M, Nicoloso MS, Calin GA. MicroRNAs and cancer—new paradigms in molecular oncology. Curr Opin Cell Biol. 2009;21:470–9.PubMedCrossRef

27.

Bánfai B, Jia H, Khatun J, Wood E, Risk B, Gundling WE, et al. Long noncoding RNAs are rarely translated in two human cell lines. Genome Res. 2012;22:1646–57.PubMedCentralPubMedCrossRef

28.

Sleutels F, Zwart R, Barlow DP. The non-coding air RNA is required for silencing autosomal imprinted genes. Nature. 2002;415:810–3.PubMedCrossRef

29.

Seidl CIM, Stricker SH, Barlow DP. The imprinted Air ncRNA is an atypical RNAPII transcript that evades splicing and escapes nuclear export. EMBO J. 2006;25:3565–75.PubMedCentralPubMedCrossRef

30.

Nagano T, Fraser P. Emerging similarities in epigenetic gene silencing by long noncoding RNAs. Mamm Genome. 2009;20:557–62.PubMedCrossRef

31.

Willingham AT, Orth AP, Batalov S, Peters EC, Wen BG, Aza-Blanc P, et al. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science. 2005;309:1570–3.PubMedCrossRef

32.

Fejes-Toth K, Sotirova V, Sachidanandam R, Assaf G, Hannon GJ, Kapranov P, et al. Post-transcriptional processing generates a diversity of 5’-modified long and short RNAs. Nature. 2009;457:1028–32.PubMedCentralCrossRef

33.

Tam OH, Aravin AA, Stein P, Girard A, Murchison EP, Cheloufi S, et al. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature. 2008;453:534–8.PubMedCentralPubMedCrossRef

34.

Watanabe T, Totoki Y, Toyoda A, Kaneda M, Kuramochi-Miyagawa S, Obata Y, et al. Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature. 2008;453:539–43.PubMedCrossRef

35.

Czech B, Malone CD, Zhou R, Stark A, Schlingeheyde C, Dus M, et al. An endogenous small interfering RNA pathway in Drosophila. Nature. 2008;453:798–802.PubMedCentralPubMedCrossRef

36.

Okamura K, Chung W-J, Ruby JG, Guo H, Bartel DP, Lai EC. The Drosophila hairpin RNA pathway generates endogenous short interfering RNAs. Nature. 2008;453:803–6.PubMedCentralPubMedCrossRef

37.

Munroe SH, Lazar MA. Inhibition of c-erbA mRNA splicing by a naturally occurring antisense RNA. J Biol Chem. 1991;266:22083–6.PubMed

38.

Beltran M, Puig I, Peña C, García JM, Alvarez AB, Peña R, et al. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev. 2008;22:756–69.PubMedCentralPubMedCrossRef

39.

Cai X, Cullen BR. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA. 2007;13:313–6.PubMedCentralPubMedCrossRef

40.

Cunnington MS, Koref MS, Mayosi BM, Burn J, Keavney B. Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genet. 2010;6:e1000899.PubMedCentralPubMedCrossRef

41.

Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071–6.PubMedCentralPubMedCrossRef

42.

Lai M, Yang Z, Zhou L, Zhu Q, Xie H, Zhang F, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2012;29:1810–6.PubMedCrossRef

43.

Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, Gillet C, et al. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol. 2007;25:1239–46.PubMedCrossRef

44.

Iacoangeli A, Lin Y, Morley EJ, Muslimov IA, Bianchi R, Reilly J, et al. BC200 RNA in invasive and preinvasive breast cancer. Carcinogenesis. 2004;25:2125–33.PubMedCrossRef

45.

Lottin S. Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis. 2002;23:1885–95.PubMedCrossRef

46.

Berteaux N, Lottin S, Monté D, Pinte S, Quatannens B, Coll J, et al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem. 2005;280:29625–36.PubMedCrossRef

47.

Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu M, et al. Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis. 2014;5:e1008.PubMedCentralPubMedCrossRef

48.

Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009;458:719–24.PubMedCentralPubMedCrossRef

49.

Cayre A, Rossignol F, Clottes E, Penault-Llorca F. aHIF but not HIF-1alpha transcript is a poor prognostic marker in human breast cancer. Breast Cancer Res. 2003;5:R223–30.PubMedCentralPubMedCrossRef

50.

Rossignol F, Vaché C, Clottes E. Natural antisense transcripts of hypoxia-inducible factor 1alpha are detected in different normal and tumour human tissues. Gene. 2002;299:135–40.PubMedCrossRef

51.

Chen W, Böcker W, Brosius J, Tiedge H. Expression of neural BC200 RNA in human tumours. J Pathol. 1997;183:345–51.PubMedCrossRef

52.

Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F, Williams GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene. 2009;28:195–208.PubMedCrossRef

53.

Mourtada-Maarabouni M, Hedge VL, Kirkham L, Farzaneh F, Williams GT. Growth arrest in human T-cells is controlled by the non-coding RNA growth-arrest-specific transcript 5 (GAS5). J Cell Sci. 2008;121:939–46.PubMedCrossRef

54.

Giannoukakis N, Deal C, Paquette J, Goodyer CG, Polychronakos C. Parental genomic imprinting of the human IGF2 gene. Nat Genet. 1993;4:98–101.PubMedCrossRef

55.

Ariel I. The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol Pathol. 2000;53:320–3.PubMedCentralPubMedCrossRef

56.

Lustig-Yariv O, Schulze E, Komitowski D, Erdmann V, Schneider T, de Groot N, et al. The expression of the imprinted genes H19 and IGF-2 in choriocarcinoma cell lines. Is H19 a tumor suppressor gene? Oncogene. 1997;15:169–77.PubMedCrossRef

57.

Adriaenssens E, Dumont L, Lottin S, Bolle D, Leprêtre A, Delobelle A, et al. H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression. Am J Pathol. 1998;153:1597–607.PubMedCentralPubMedCrossRef

58.

Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129:1311–23.PubMedCentralPubMedCrossRef

59.

Silva JM, Boczek NJ, Berres MW, Ma X, Smith DI. LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol. 2011;8:496–505.PubMedCrossRef

60.

Bernard D, Prasanth KV, Tripathi V, Colasse S, Nakamura T, Xuan Z, et al. A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J. 2010;29:3082–93.PubMedCentralPubMedCrossRef

61.

Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 2010;39:925–38.PubMedCrossRef

62.

Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, Wu X, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet. 2013;9:e1003368.PubMedCentralPubMedCrossRef

63.

Geirsson A, Lynch RJ, Paliwal I, Bothwell ALM, Hammond GL. Human trophoblast noncoding RNA suppresses CIITA promoter III activity in murine B-lymphocytes. Biochem Biophys Res Commun. 2003;301:718–24.PubMedCrossRef

64.

Geirsson A, Bothwell ALM, Hammond GL. Inhibition of alloresponse by a human trophoblast non-coding RNA suppressing class II transactivator promoter III and major histocompatibility class II expression in murine B-lymphocytes. J Heart Lung Transplant. 2004;23:1077–81.PubMedCrossRef

65.

Lanz RB, McKenna NJ, Onate SA, Albrecht U, Wong J, Tsai SY, et al. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell. 1999;97:17–27.PubMedCrossRef

66.

Lanz RB, Chua SS, Barron N, Soder BM, DeMayo F, O’Malley BW. Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Mol Cell Biol. 2003;23:7163–76.PubMedCentralPubMedCrossRef

67.

Leygue E, Dotzlaw H, Watson PH, Murphy LC. Expression of the steroid receptor rna activator in human breast tumors. Cancer Res. 1999;59:4190–3.PubMed

68.

Murphy LC, Simon SLR, Parkes A, Leygue E, Dotzlaw H, Snell L, et al. altered expression of estrogen receptor coregulators during human breast tumorigenesis. Cancer Res. 2000;60:6266–71.PubMed

69.

Wang F, Li X, Xie X, Zhao L, Chen W. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett. 2008;582:1919–27.PubMedCrossRef

70.

Erwin JA, Lee JT. New twists in X-chromosome inactivation. Curr Opin Cell Biol. 2008;20:349–55.PubMedCentralPubMedCrossRef

71.

Benoît M-H, Hudson TJ, Maire G, Squire JA, Arcand SL, Provencher D, et al. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines. Int J Oncol. 2007;30:5–17.PubMed

72.

Yildirim E, Kirby JE, Brown DE, Mercier FE, Sadreyev RI, Scadden DT, et al. Xist RNA is a potent suppressor of hematologic cancer in mice. Cell. 2013;152:727–42.PubMedCrossRef

73.

Askarian-Amiri ME, Crawford J, French JD, Smart CE, Smith MA, Clark MB, et al. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA. 2011;17:878–91.PubMedCentralPubMedCrossRef

74.

Raouf A, Sun Y, Chatterjee S, Basak P. The biology of human breast epithelial progenitors. Semin Cell Dev Biol. 2012;23:606–12.PubMedCrossRef

Titel: Functional significance of long non-coding RNAs in breast cancer
verfasst von: Rajeev Vikram
Rahul Ramachandran
Khaja Shameem Mohammed Abdul
Publikationsdatum: 01.09.2014
Verlag: Springer Japan
Erschienen in: Breast Cancer / Ausgabe 5/2014
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI: https://doi.org/10.1007/s12282-014-0554-y

Neu im Fachgebiet Onkologie

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Functional significance of long non-coding RNAs in breast cancer

Abstract

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2014

Clinicopathological features of gastric metastasis from breast cancer in three cases

Gene delivery of cyclin-dependent kinase inhibitors p21 Waf1 and p27 Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro

Cost-effectiveness analysis for breast cancer screening: double reading versus single + CAD reading

GeneSearch™ BLN Assay could replace frozen section and touch imprint cytology for intra-operative assessment of breast sentinel lymph nodes

Preoperative endocrine therapy with goserelin acetate and tamoxifen in hormone receptor-positive premenopausal breast cancer patients

Sentinel lymph node biopsy in breast cancer patients with previous breast augmentation surgery

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie